Deceased Donor Kidney Storage at 10 Celsius Versus Conventional Storage (NCT07385651) | Clinical Trial Compass
RecruitingNot Applicable
Deceased Donor Kidney Storage at 10 Celsius Versus Conventional Storage
United States30 participantsStarted 2024-11-18
Plain-language summary
The goal of this clinical trial is to test how storage temperature of deceased donor kidneys affects kidney function after transplant in adult patients receiving a kidney transplant.
The main question it aims to answer is:
• Do patients that receive a kidney transplant stored at 10 °C have improved post-transplant kidney function? Researchers will compare patients who receive kidneys stored at 10 °C versus kidneys stored at 4°C (on ice, i.e. conventional storage) to see if kidneys stored at 10 °C have improved function.
Participants will:
* Be made aware of and consent to receive a kidney transplant that had been stored at 10 °C
* Have their urine collected 24 hours after surgery to be analyzed for research
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Exclusion criteria
. Kidney transplant candidates less than 18 years old
. Kidney transplant candidates that decline consent
. Transplant candidates listed for multi-organ transplant
. Donation after brain death or donation after circulatory death kidney donors, whose health care proxy has consented for donation and the possibility of research
. Deceased donor kidneys that have been allocated to VUMC as a primary match offer prior to organ procurement will be eligible
. Donors whose health care proxy has declined consent for the possibility of research
. Deceased donor kidneys that have been allocated to VUMC as a backup offer
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Urine NGAL
Timeframe: Urine collected post operatively day one after kidney transplant